Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Ebiomedicine|September 20, 2024
Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancerTrinh T T Tran, Cao Dai Phung, Brendon Z J Yeo, et al.
British Journal of Cancer|June 18, 2021
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studiesSebastian Bauer, George D Demetri, Ensar Halilovic, et al.
Scientific Reports|March 1, 2016
Microfluidic enrichment for the single cell analysis of circulating tumor cellsTrifanny Yeo, Swee Jin Tan, Chew Leng Lim, et al.
Cancer|February 3, 2015
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysisN Gopalakrishna Iyer, Daniel S W Tan, Veronique K M Tan, et al.
JTO Clinical and Research Reports|January 13, 2022
Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2022
Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001Caroline E McCoach, Christian Rolfo, Alexander Drilon, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2021
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signaturesYvonne H F Teng, Hong Sheng Quah, Lisda Suteja, et al.
Developmental Cell|August 1, 2024
Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitorsShen Yon Toh, Hui Sun Leong, Fui Teen Chong, et al.
Head & Neck|June 24, 2014
Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinomaSiok-Hoon Ang, Benjamin Haaland, Sanchalika Acharyya, et al.
JTO Clinical and Research Reports|January 1, 2024
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate MeasureStephanie P L Saw, Gek San Tan, Wei Chong Tan, et al.
Pageof 13